Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regression

Hepatology

Volumn 25, Issue 4, 1997, Pages 906-912

  Grasl Kraupp, Bettina ^a   Ruttkay Nedecky, Branislav ^a   Müllauer, Leonhard ^b   Taper, Henryk ^c   Huber, Wolfgang ^a   Bursch, Wllfried ^a   Schulte Hermann, Rolf ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Inst für Klinische Pathologie   (Austria)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

NAFENOPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER THERAPY; CELL DIVISION; CELL LOSS; LIVER CARCINOGENESIS; LIVER CELL; MALE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; TUMOR REGRESSION;

ADENOMA, LIVER CELL; ANIMALS; APOPTOSIS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; DNA, NEOPLASM; HUMANS; LIVER; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; NAFENOPIN; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 0030915471     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250420     Document Type: Article

References (20)

1. Cooper EH, Bedford AJ, Kenny TE. Cell death in normal and malignant tissues. Adv Cancer Res 1975;21:59-120.
2. Wright NA. The tissue kinetics of cell loss. In: Bowen ID, Lockshin RA, eds. Cell Death in Biology and Pathology. London, New York: Chapman and Hall, 1981:171-207.
3. Wyllie AH. The biology of cell death in tumors. Anticancer Res 1985;5:131-136.
4. Sarraf CE, Bowen ID. Kinetic studies on a murine sarcoma and an analysis of apoptosis. Br J Cancer 1986;54:989-998.
5. Moore JV. Death of cells and necrosis of tumours. In: Potten CS, ed. Perspectives on Mammalian Cell Death. New York: Oxford University Press, 1987:295-325.
6. Michalopoulos GK. Liver regeneration and growth factors: old puzzles and new perspectives. Lab Invest 1992;67:413-415.
7. 1. Proc Natl Acad Sci U S A 1992;89:5408-5412.
8. Fausto N, Webber EM. Mechanisms of growth regulation in liver regeneration and hepatic carcinogenesis. In: Boyer JL, Ockner RK, eds. Progress in Liver Diseases. Philadelphia, Saunders, 1993:115-137.
9. Nagy P, Bisgaard HC, Thorgeirsson SS. Expression of hepatic transcriptional factors during liver development and oval cell differentiation. J Cell Biol 1994;126:223-233.
10. Grasl-Kraupp B, Bursch W, Ruttkay-Nedecky B, Wagner A, Lauer B, Schulte-Hermann R. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acad Sci U S A 1994;91:9996-9999.
11. Schulte-Hermann R, Bursch W, Grasl-Kraupp B. Active cell death (apoptosis) in liver biology and disease. In: Boyer JL, Ockner RK, eds. Progress in Liver Diseases. Philadelphia, Saunders, 1995:1-35.
12. Okuda K, Kojiro M, Okuda H. Neoplasms of the liver. In: Schiff L, Schiff ER, eds. Diseases of the Liver. Philadelphia, Lippincott, 1993:1236-1296.
13. Pilot HC, Dragan YP. Facts and theories concerning the mechanisms of carcinogenesis. FASEB J 1991;5:2280-2286.
14. Bursch W, Lauer B, Timmermann-Trosiener I, Barthel G, Schuppler J, Schulte-Hermann R. Controlled cell death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 1984;5:453-458.
15. Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W. DNA synthesis, apoptosis, and phenotype expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 1990;50:5127-5135.
16. Lake BG. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annu Rev Pharmacol Toxicol 1995;35:483-507.
17. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990;347:645-650.
18. Moody DE, Reddy JK. Morphometric analysis of the ultrastructural changes in rat liver induced by the peroxisome proliferator SaH 42-348. J Cell Biol 1976;71:768-780.
19. Greaves P, Irisarri E, Monro AM. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility. J Natl Cancer Inst 1986;76:475-484.
20. Marsman DS, Popp JA. Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643. Carcinogenesis 1994;15:111-117.